Meeting
2016 ASCO Annual Meeting
Predicting overall survival (OS) and progression-free (PFS) for oropharynx cancers (OPC) in NRG Oncology RTOG0129/0522 with nomograms.
Authors
Carole Fakhry
Johns Hopkins University, Baltimore, MD
Carole Fakhry , Qiang Zhang , Maura L. Gillison , Phuc Duy Nguyen , David Ira Rosenthal , Randal S. Weber , Louise Lambert , Andy Trotti , William Barrett , Wade Thorstad , Sue S Yom , Stuart J. Wong , John A. Ridge , Shyam S. Rao , James A. Bonner , Eric Vigneault , David Raben , Jonathan Harris , Quynh-Thu Le
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6024)
DOI
10.1200/JCO.2016.34.15_suppl.6024
Abstract #
6024
Poster Bd #
346
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Neck dissection rate in node positive human papillomavirus associated oropharyngeal carcinoma following chemoradiotherapy.
First Author: Sandro Porceddu
Poster
2014 ASCO Annual Meeting
Risk factors predictive for poor outcomes in patients with human papillomavirus (HPV)-initiated oropharyngeal cancer (OPC).
First Author: Tobenna Igweonu Nwizu
Poster
2023 ASCO Annual Meeting
Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
First Author: Robert L. Ferris
Poster
2023 ASCO Annual Meeting
Association of HPV genotype and phylogenic clade with oropharyngeal cancer outcomes.
First Author: Michael Wotman